Candriam S.C.A. Procept Bio Robotics Corp Transaction History
Candriam S.C.A.
- $16.8 Billion
- Q2 2025
A detailed history of Candriam S.C.A. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Candriam S.C.A. holds 63,125 shares of PRCT stock, worth $2.42 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
63,125
Previous 30,824
104.79%
Holding current value
$2.42 Million
Previous $1.8 Million
102.56%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
303Shares Held
43.5MCall Options Held
286KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$197 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$134 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$82.3 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$54.4 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$49.9 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.71B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...